|
These interviews, presentations, and panel discussions took place at the BPI Theater at BIO 2021. Centering the presentations around two key themes — emerging therapies and technologies — enabled theater speakers and attendees to engage complex, interconnected topics that are of interest to BPI readers. Speakers highlighted how their companies are responding to both challenges and opportunities relating to manufacturing technique and capacity, particularly where it concerns expressing and mass-producing novel proteins. Presenters also reflected on how far the biopharmaceuticals industry has come, the challenges it faces with COVID-19, and where it can go in the age of individualized cell and gene therapies.
View the full presentations by following the links below.
|
